Metadata
Author: Giga-fren
Data
English[en]
The proposed indication for Vantas® is for the palliative treatment of patients with hormone-dependent advanced prostate carcinoma (Stage M1[TNM] or Stage D2 [AUA]).
French[fr]
L’indication proposée pour VantasMD est le traitement palliatif des formes avancées du cancer de la prostate hormonodépendant (stade M1[classification TNM] ou stade D2 [classification AUA]).